Subscribe to the newsletterForward | Contact | www.lyonbiopole.com   November 2011
 
A LA UNE
2011/10/20 - Lyonbiopole presents its good results in Paris

Lyonbiopole, which gathers 110 members, most of whom are small and medium-sized biotechnology companies, confirms its ambition and dynamism serving companies. Lyonbiopole shows significant results and has met the objectives set in its performance contract for 2009-2011 meaning: accelerating innovation in French biotech and biopharmaceutical SMBs to develop competitiveness of companies; strengthening the excellence of the clusters’ R&D to attract more and more investment and talents.

Learn more


2011/09/30 - With € 180M of state aid, LyonBioTech is the best Institute amongst the six projects selected

The state aid dedicated to LyonBioTech announced on September 30, amounts to € 180 million of state aid distributed in € 89 million of expendable endowment and € 300 million for non-expendable endowment. Co-founded by Lyonbiopole and the Institut Pasteur, LyonBioTech firmly follows an objective of economic and industrial development. It aims to establish a firm foothold for health industries in the territory and foster the growth of small and medium-sized businesses in tomorrow’s sectors, while addressing public health issues related to infectious diseases and microbiota. Nearly 50,000 sq.ft/ 5,000 sq.m of real estate dedicated to the TRI, on a total of 400,000 sq.ft./ 30 to 40,000 sq.m on a the long term period, will be available on Lyon Gerland and the Institut Pasteur Paris sites.

Learn more


2011/10/07 – Partnering Days: a confirmed success for the 5th edition

Once again, the 2011 Edition has been a success with over 270 attendees during the day: 38% of SMEs, 21% of industrials, 32% of academics and 9% of partners. The "Partnering Days", the annual meeting of Lyonbiopole, are a place of privileged exchanges between all the members of the cluster involved in the fight against infectious diseases and cancers. Besides the presentation of the strategic areas in which Lyonbiopole is involved, the R&D projects of the cluster and the existing funding programmes, these days are also an opportunity to exchange and build new partnerships around scientific parallel roundtables. The 5th edition enabled to present the technological and economic benefits of the 1st collaborative R&D projects helped thanks to the FUI and that are coming to an end.

Learn more



ZOOM SUR
CTI Lyon

CTI-LYON, Cell Therapy research Institute contributes to the development of new cell therapies to advance the treatment of diseases such as cerebral palsy, stroke, diabetes, cancer, orthopaedic and craniofacial malformations, blood, immune system, liver and cardiovascular diseases.
CTI-LYON specializes in research on adult stem cells (bone marrow, fat) and from umbilical cord cells that have tremendous potential for tissue repair.

Learn more



A LA UNE
From 2011/10/03 to 2011/10/06 - Lyonbiopole supports 20 French companies to participate in an exploratory mission in the North of Europe (Scandinavia and Finland)

20 French companies, supported by 6 French health clusters participated in the collective mission in the North of Europe (Denmark, Sweden and Finland). The mission was supported by the DGCIS, the French Ministry of Industry and co-organised by UBIFrance and Medicen. During this 4-day mission, French companies met 2 Scandinavian Big Pharmas (Lundbeck and Novo Nordisk), the main Clusters of the Region and their research centers. The participants also benefited from B2B meetings with local companies organized during the whole mission.
Contact : Isabelle Scarabin, Director Economic & International Affairs Director - isabelle.scarabin@lyonbiopole.com
Emilie Romeo, Project manager  – emilie.romeo@lyonbiopole.com

Learn more


2011/11/08 - Lyonbiopole co-organizes the 3rd edition of Nosocomial Infections day

This event will take place on November 8th, 2011, at "Institut Français de l’Education" (19, allée de Fontenay 69007 Lyon). Organized by Lyonbiopole and the Finovi Foundation, in partnership with SHAM (insurance and risks management / health and medical-social sector), the day will focus on conferences and discussion to explore the various issues raised by nosocomial infections. These conferences will focus on: fungal infections in the morning and multi-resistance of pathogens in the afternoon. Registration for this event are required (seating limited to 120 people).
Contact: Pauline Cottin, Sepsis Program Coordinator, in charge of the organization of this day - pauline.cottin@lyonbiopole.com

Learn more


2011/11/11 to 2011/11/17 - Participate to the International mission French Life Sciences clusters on "Neurosciences" on US East Coast

Lyonbiopole invites you to participate to the international mission “Neurosciences” organized together with all French Life Science clusters from November 11th to 17th 2011 on the US East Coast (Washington and Boston). This mission is initiated by a partnership of the French Biotech competitiveness clusters, coordinated by Alsace Biovalley cluster, the DGCIS (French ministry of Economy, finances and industry), Ubifrance’s team in the US and France.
Contact: Kevin Romani - International Project Manager - kevin.romani@lyonbiopole.com

Learn more


2011/11/10 - Professeur Elizabeth Blackburn  will give a Lecture about "Assessing Telomere Health for Clinical Science and Application" in Lyon

Pr. Elizabeth H. Blackburn, Morris Herztein Professor of Biology and Physiology in the Department of Biochemistry and Biophysics at the University of California, San Francisco. Leader in the area of telomere and telomerase research, she will give a lecture about "Assessing Telomere Health for Clinical Science and Application", on November the 10th, at 4:00 pm, at the International Agency for Cancer Research, 150 Cours Albert Thomas, Lyon 3ème.
Contact : Estelle Vincent, Project Management Assistant - estelle.vincent@lyonbiopole.fr

Learn more


2011/12/01 and 2011/12/02 – 2nd International Symposium "Microbes for Health" organized by Danone Research in Paris

Danone Research, the Institut Pasteur and INRA, partners of the Technological Research Institute LyonBioTech, are co-organizing the 2nd International Symposium "Microbes for Health" to be held in Paris on December 1st and 2nd, 2011. The objective of this symposium is to share in the scientific community the recent results in the field of intestinal flora, including the role of these bacteria on human health. This field of research is currently boosted, which opens up many possibilities for the future of health and nutrition.

Learn more


2011/12/07 - UbiFrance organizes the 1st edition of the International Health Meetings (RIS) in Paris

This day aims to inform you, exchange to speed up your international development in the presence of key industry players and around 14 countries: South Africa, Germany, Saudi Arabia, Australia, Brazil, Canada, Chile, China, Spain, United States, Finland, Israel, UK and Russia. The goal is to offer companies of the health sector, meetings with UBIFRANCE experts and logistics expert in life sciences. Around these meetings, will be organized: a lecture by Bruno Rougier, France Info journalist specialized in health and sectoral workshops and Information & Export Advice (OSEO, INPI, Coface, V.I.E, ...). Lyonbiopole is a partner in this first edition.

Learn more



AGENDA
Next Life Science events:
   
Rare 2011, «Innovation and partnerships for patients»,
November 2nd, 2011, Montpellier - France
3rd edition of Nosocomial Infections Day,
November 8th, 2011, Lyon - France
Competitiveness clusters mission: Neurosciences 2011,
November from 12th to 16th, 2011, Washington, DC - USA
2nd International Symposium "Microbes for Health"
December from 1st to 2nd, 2011, Paris - France
3rd edition, Private Investment Day,
December 2nd, 2011, Lyon - France
1st edition of the International Health Meetings (RIS),
December 7th, 2011, Paris - France
BIO-Europe Spring® Conference,
March from 19th to 21st, 2012, Amsterdam - The Netherlands
Biomarker World Congress 2012,
May from 21st to 23th, 2012, Philadelphia PA - USA
BIO International Convention,
June from 18th to 21st, 2011, Boston MA - USA
 
A LA UNE
2011/12/15 - 1st call for proposals between France, OSEO and Japan NEDO

Following the cooperation agreement signed last year with NEDO (Japan), a French-Japanese call for projects is jointly launched by the two signatories, OSEO and NEDO. The purpose of this call is to identify projects for technology and R&D partnerships initiated by companies of both countries that could benefit from funding from both sides. The industrial and technological sectors concerned are: materials and electronic technologies and nanotechnology, biotechnology and medical technology, environmental technology, production systems.
Contacts : Isabelle Lebo, isabelle.lebo@oseo.fr et Jean-Jacques Yarmoff, international@ml.nedo.go.jp, both in charge of the program.

Learn more


2012/01/15 - Call for projects PSPC: latest round of presets files in mid-November

The call « projets de R&D structurants des pôles de compétitivité" (PSPC) » is open until January 15th, 2012.  To be eligible, your project must be a collaborative R&D project with an investment between 8 and 50 million Euros. The project must be accredited by a French Competitiveness Cluster and must involve at least 2 businesses and one laboratory or research center. Lyonbiopole helps you in setting up yours projects and study your project’s accreditation request.
Contact : Claudia Chagneau, Project Manager - claudia.chagneau@lyonbiopole.com

Learn more


2012/01/30 - The 1st  " plate-formes mutualisées d’innovation " (PFMI) call

The « plate-formes mutualisées d’innovation « (PFMI) call is open until 2012, January 30th on the www.competitivite.gouv.fr website. To apply, the platforms must offer mutualized resources in open access. The projects must be accredited by at least one French competitiveness cluster and key businesses in the sector must be part of it.
Lyonbiopôle can advice you in setting up yours projects and study project’s accreditation request.
Contact : Claudia Chagneau, Project Manager - claudia.chagneau@lyonbioole.com - claudia.chagneau@lyonbiopole.com

Learn more


2011/12/06 -  FP7 Capacities “Research for SMEs” 2012 Call is now open

The call FP7 Capacities dedicated to "Research for SMEs" is open until December 6th, 2011. This program aims to strengthen the innovation capacity of European SMEs. It includes 3 activities: "Research for SMEs" (R&D outsourced to technology providers), "Research for SME Associations" (R&D performed by technology providers on behalf of associations representing SMEs in a certain area industrial) and "Demonstration activity". Lyonbiopole proposes its expertise to set-up European projects, within its PPTE program.
Contact: Emilie Romeo, Project manager - emilie.romeo@lyonbiopole.com

Learn more


2011/01/03 – 8th Eurostars Cut-off is now open

The 8th Eurostars Cut-off is now open. The deadline for submission is on March 1st, 2012. Lyonbiopole proposes its expertise to set-up European projects, within its PPTE program.
Contact: Emilie Roméo, Project manager - emilie.romeo@lyonbiopole.com

Learn more



A LA UNE
2011/11/04 - Lyonbiople welcomes the National Research Agency (ANR)

In the framework of Lyonbiopole’s Lunch Break Partnering, Matthieu Levi-Strauss of the National Research Agency (ANR) will present the 2012 work programme of the ANR funding mechanism on November 4th from 11:00 to 14:00 at Lyonbiopole’s headquarters. After the presentation, 2 leaders of ANR projects will bring their testimonies. All the speeches will be followed by exchanges between the participants and the speakers.
Contact: Claudia Chagneau, Project manager - claudia.chagneau@lyonbiopole.com

Learn more


2011/10 - Two new intensive care units become partners in the Sepsis program

Sepsis program has integrated into its clinical network, the intensive care units of Pr B.Allaouchiche of Lyon University Hospital and Professor C.Auboyer of CHU Saint Etienne. They join three intensive care units of Pr JF Timsit JF - CHU de Grenoble, Dr Alain Lepape - CHU de Lyon and Dr. Fabrice Zeni - CHU de Saint Etienne.

Learn more


From 2011/11/21 to 2011/11/30 - Lyon and Grenoble, in the race for Guyana

Two women's teams from Lyonbiopole will participate in the 10th edition of the “Raid Amazone” or the “Green Tree Raid”. The LyonBioTeam gathers Pauline Cottin from Lyonbiopole, Marine Willemse from Bluestar Silicones and Emilie Fourt from SECR and the GIN Team is composed by Audrey Jordana and Muriel Verges of PX'Therapeutics and Manuela De Oliveira from the Tonkin Clinic. For 10 days, LyonBioTeam and GIN Team will exceed during this expedition comprising orienteering race and hiking, canoeing, mountain biking, archery and climbing in team and thus will promote Lyon and Grenoble regions showing their energy.

Learn more


2011/09/26 - Sanofi announces the establishment of Merial’s world headquarter in Lyon

Merial, division of Sanofi group and world leader in animal health, will establish its world headquarter in Lyon and thus transfer its activities from Atlanta (US) to Lyon, where Merial is historically represented with 1 400 employees and six sites in Lyon and its region. Merial's world headquarter will be domiciled in the Gerland area, on the avenue Tony Garnier - the historic place of biological vaccine manufacturing.

Learn more


2011/09/23 - Magnisense Receives Japanese Patent for its MIAtek® Technology

Magnisense, a developer of next generation bioassays for human and animal diagnostics, food safety and environmental protection, announced that it received notification that its Russian Patent No. 20000105511, originally issued in Russia in 2001, covering fundamental aspects of Magnisense’s MIAtek® technology, has been issued in Japan (Japanese Patent No. 565986). In addition to Russia, this patent was previously issued in other areas of the world, including the U.S. and Europe.

Learn more


2011/10/05 - Pink October: ImmunID Enters Into The Battle Against Breast Cancer

Chemotherapy is usually the first-line treatment after a diagnosis of metastatic breast cancer. However, women do not all have the same capacity to respond to the disease and its treatment. So, how should the therapy best be adapted to each patient? Divpenia, a biomarker developed by ImmunID, measures the fragility of the adaptive immune system. Ongoing clinical research at the Centre Léon Bérard in Lyon shows that divpenia could provide doctors with relevant information to help them choose the appropriate therapy for each patient. The hope that one day this biomarker will become part of the arsenal of predictive tools used in the fight against this dreadful disease seems justified. During Pink October, ImmunID is taking a stand against breast cancer along with everyone in the healthcare sector.

Learn more


2011/10/11 - EVEON has obtained new certifications ISO 13485 & ISO 9001

EVEON, which designs and develops medical systems for preparing and/or administering medication via the parenteral route, has obtained its double certification This means it can guarantee its customers a high level of quality during the design and development of its innovative medical devices, while complying with regulatory requirements.

Learn more


2011/10/08 - Pancreatic cancer: An award for the Centre Léon Bérard

On October 18th, Laurent Bartholin, researcher the Inserm’s Cancer Research Center, on the site of the Centre Léon Bérard, received the award of "Young Researcher in Cancer ", for his researches on pancreatic cancers. The award ceremony took place at the Centre Léon Bérard. A € 3,000 check was dedicated to his laboratory, for the second consecutive year, by the President of the Friends of Lyon’s University and by the President of Ain’s Committee of the National League against Cancer.

Learn more

 
© Lyonbiopole 2019  |  CREDITS  |  LEGAL NOTICE  |